BioAsia bestows Bharat Biotech with Genome Valley Excellence Award for 2021
BioAsia bestows Bharat Biotech with Genome Valley Excellence Award for 2021
17 February 2021 | News Bharat Biotech was selected by the International Advisory Board of BioAsia
BioAsia has announced that the prestigious Genome Valley Excellence Award for the year 2021 will be bestowed upon Bharat Biotech International Limited for its breakthrough, pioneering research, development and commercialisation of vaccines including COVAXIN™ (COVID-19 Vaccine), Rabies vaccine, Rotavirus vaccine, Japanese Encephalitis vaccine, Polio vaccine and Typhoid Conjugate vaccines, among others that have helped save billions of lives globally.
Dr Krishna M Ella, Chairman & Managing Director, and Suchitra Ella, Joint Managing Director, Bharat Biotech International will receive the award on February 22, 2021, during the inaugural event of BioAsia 2021.
BioAsia to be held virtually this year
Updated:
Updated:
30,000 life sciences professionals expected to participate, CEO Shakthi Nagappan
Share Article
AAA
Industries and IT Minister K.T. Rama Rao unveiling the logo and theme of the 18th edition of BioAsia, scheduled on February 22-23.
30,000 life sciences professionals expected to participate, CEO Shakthi Nagappan
BioAsia, a premier annual event devoted to the Life Sciences sector that attracts participants from across the world, will be conducted virtually this year.
Unveiling logo and theme of the 18th edition of BioAsia, scheduled on February 22-23, Industries and IT Minister K.T. Rama Rao said it will be for the first time that the event will be held virtually. The flagship event of the State, BioAsia has emerged as an important global platform to deliberate on the opportunities, challenges and solutions for the Life Sciences sector. “As the world is walking a perilous path to fight one of the most challenging